Claudin-9 (CLDN9) promotes gastric cancer progression by enhancing the glycolysis pathway and facilitating PD-L1 lactylation to suppress CD8+ T cell anti-tumor immunity by Xingbin Hu, Wenhao Ouyang, Haizhu Chen, Zhihong Liu, Zijia Lai, Herui Yao

Get full text

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma by Qian Hu, Xiao Lin, Linxiaoxiao Ding, Yinduo Zeng, Danmei Pang, Nengtai Ouyang, Yanqun Xiang, Herui Yao

Get full text

Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment by Xiuping Lai, Di Cheng, Huixin Xu, Jingshu Wang, Xiaozhi Lv, Herui Yao, Liuning Li, Junyan Wu, Suiwen Ye, Zhihua Li

Get full text

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer by Yunfang Yu, Ying Wang, Luhui Mao, Suiwen Ye, Xiuping Lai, Junyi Chen, Yiwen Zhang, Jieqiong Liu, Junyan Wu, Tao Qin, Herui Yao

Get full text

Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer by Yunfang Yu, Gengyi Cai, Ruichong Lin, Zehua Wang, Yongjian Chen, Yujie Tan, Zifan He, Zhuo Sun, Wenhao Ouyang, Herui Yao, Kang Zhang

Get full text

Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives by Zhenjun Huang, Qing Peng, Luhui Mao, Wenhao Ouyang, Yunjing Xiong, Yujie Tan, Haizhu Chen, Zebang Zhang, Tang Li, Yuanjia Hu, Ying Wang, Wei Zhang, Herui Yao, Yunfang Yu

Get full text

A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast c... by Jingshu Wang, Xiuping Lai, Herui Yao, Hui Yang, Xiaolong Cao, Xiaochen Wang, Ying Wang, Weiqi Nian, Xiaodong Zheng, Qingxiu Mai, Anding Liu, Xiaozhi Lv, Xiaoying Bi, Junyi Chen, Junyan Wu, Suiwen Ye

Get full text

Efficacy and safety of KN026 and docetaxel for HER2‐positive breast cancer: a phase II clinical trial by Jianli Ma, Jingxuan Wang, Ting Xu, Quchang Ouyang, Xiaojia Wang, Jingfen Wang, Lu Gan, Zhong Ouyang, Daren Lin, Tao Sun, Changping Shan, Herui Yao, Baochun Zhang, Zhengguang Li, Zhixiang Zhuang, Ying Lu, Hongwei Yang, Jian Huang, Xingwang Yang, Hongmei Sun, Qingyuan Zhang

Get full text

MRI-based multimodal AI model enables prediction of recurrence risk and adjuvant therapy in breast cancer by Yunfang Yu, Wei Ren, Luhui Mao, Wenhao Ouyang, Qiugen Hu, Qinyue Yao, Yujie Tan, Zifan He, Xiaohua Ban, Huijun Hu, Ruichong Lin, Zehua Wang, Yongjian Chen, Zhuo Wu, Kai Chen, Jie Ouyang, Tang Li, Zebang Zhang, Guoying Liu, Xiuxing Chen, Zhuo Li, Xiaohui Duan, Jin Wang, Herui Yao

Get full text